Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

被引:48
作者
Leong T.T. [1 ]
Fearon U. [1 ]
Veale D.J. [1 ]
机构
[1] Department of Rheumatology, St. Vincent's University Hospital and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin
关键词
Vascular Endothelial Growth Factor; Psoriasis; Infliximab; Pioglitazone; Psoriatic Arthritis;
D O I
10.1007/s11926-005-0044-5
中图分类号
学科分类号
摘要
Psoriasis is a common chronic dermatosis occurring in 2% of the population and associated with an inflammatory arthritis--psoriatic arthritis (PsA)--in up to 40% of cases. PsA accounts for approximately 15% of patients attending early synovitis clinics, therefore it represents the second most common diagnostic category after rheumatoid arthritis. There are a number of common pathogenic features that link the skin and the joint inflammatory processes. Angiogenesis appears to be a fundamental inflammatory response early in the pathogenesis and significant abnormalities of vascular morphology and angiogenic growth factors have been described in psoriasis and PsA. This paper will explore the recent published evidence to support the hypothesis that dysregulated angiogenesis provides a primary pathogenic mechanism in psoriasis skin and in the PsA joint.
引用
收藏
页码:325 / 329
页数:4
相关论文
共 50 条
  • [31] The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
    Blauvelt, Andrew
    Chiricozzi, Andrea
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 55 (03) : 379 - 390
  • [32] Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
    Olszewska, Barbara
    Adamski, Zygmunt
    Czarnecka-Operacz, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2018, 35 (03): : 231 - 237
  • [33] Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.
    Myers W.
    Opeola M.
    Gottlieb A.B.
    Current Rheumatology Reports, 2004, 6 (4) : 306 - 313
  • [34] Therapeutic strategies for psoriasis and psoriatic arthritis
    Wozel, G.
    HAUTARZT, 2009, 60 (02): : 91 - 99
  • [35] Identification of Psoriatic Arthritis in Patients With Psoriasis
    Coates, Laura C.
    Eder, Lihi
    Poddubnyy, Denis
    Rosen, Cheryl F.
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (11) : 25 - 26
  • [36] JAK Inhibitors for Psoriasis and Psoriatic Arthritis
    Varma, Aakaash
    Han, George
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (02) : 107 - 113
  • [37] Apremilast: A Review in Psoriasis and Psoriatic Arthritis
    Gillian M. Keating
    Drugs, 2017, 77 : 459 - 472
  • [38] Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
    Puig, Lluis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [39] Etanercept in the treatment of psoriatic arthritis and psoriasis
    Kazuki Takada
    Arthritis Research & Therapy, 3 (1)
  • [40] New biologics for psoriasis and psoriatic arthritis
    Rozenblit, Mariya
    Lebwohl, Mark
    DERMATOLOGIC THERAPY, 2009, 22 (01) : 56 - 60